{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?legislature.prefLabel=House+of+Commons&tablingMemberConstituency=Twickenham&answer.answeringMemberConstituency=Thurrock&ddpModified.=2018-01-31T14%3A42%3A01.938Z&max-answer.questionFirstAnswered.=2019-07-15T13%3A33%3A41.877Z", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?legislature.prefLabel=House+of+Commons&tablingMemberConstituency=Twickenham&answer.answeringMemberConstituency=Thurrock&ddpModified.=2018-01-31T14%3A42%3A01.938Z&max-answer.questionFirstAnswered.=2019-07-15T13%3A33%3A41.877Z", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?legislature.prefLabel=House+of+Commons&tablingMemberConstituency=Twickenham&answer.answeringMemberConstituency=Thurrock&ddpModified.=2018-01-31T14%3A42%3A01.938Z&_metadata=all&max-answer.questionFirstAnswered.=2019-07-15T13%3A33%3A41.877Z", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&legislature.prefLabel=House+of+Commons&tablingMemberConstituency=Twickenham&answer.answeringMemberConstituency=Thurrock&ddpModified.=2018-01-31T14%3A42%3A01.938Z&max-answer.questionFirstAnswered.=2019-07-15T13%3A33%3A41.877Z", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?legislature.prefLabel=House+of+Commons&tablingMemberConstituency=Twickenham&answer.answeringMemberConstituency=Thurrock&ddpModified.=2018-01-31T14%3A42%3A01.938Z&max-answer.questionFirstAnswered.=2019-07-15T13%3A33%3A41.877Z", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?legislature.prefLabel=House+of+Commons&tablingMemberConstituency=Twickenham&answer.answeringMemberConstituency=Thurrock&ddpModified.=2018-01-31T14%3A42%3A01.938Z&max-answer.questionFirstAnswered.=2019-07-15T13%3A33%3A41.877Z", "items" : [{"_about" : "http://data.parliament.uk/resources/831118", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/831118/answer", "answerText" : {"_value" : "
The Medicines and Healthcare products Regulatory Agency (MHRA) have received 124 spontaneous reports of suspected adverse drug reactions (ADRs) via the Yellow Card Scheme from prescribers and patients in association with liothyronine in the United Kingdom as of 28 January 2018. The MHRA have not received any spontaneous cases where the reporter has stated their liothyronine is unlicensed.<\/p>
<\/p>
Of the 124 reports, six relate to a brand of liothyronine that is not licensed in the UK. However, it is important to note that patients may have been prescribed a medication while in a foreign country; therefore, a report of a foreign brand cannot be assumed as unlicensed use. Furthermore, while reporters are requested to provide as much detail as possible, detail of the medicinal brand or license is not a compulsory reporting criteria. Therefore, this information is not always provided.<\/p>
<\/p>
Yellow Card data should not be used as an indicator of the frequency of suspected ADRs to medicines. The level of ADR reporting may fluctuate over time due to a variety of reasons such as a medicine being new, stimulated interest/publicity and variations in exposure to the medicine.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4065", "label" : {"_value" : "Biography information for Dame Jackie Doyle-Price"} } , "answeringMemberConstituency" : {"_value" : "Thurrock"} , "answeringMemberPrinted" : {"_value" : "Jackie Doyle-Price"} , "dateOfAnswer" : {"_value" : "2018-01-31", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2018-01-31T14:09:34.423Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2018-01-26", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Liothyronine"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, how many reports have been made by prescribers or patients to the Medicines and Healthcare products Regulatory Agency on unlicensed liothyronine.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/207", "label" : {"_value" : "Biography information for Sir Vince Cable"} } , "tablingMemberConstituency" : {"_value" : "Twickenham"} , "tablingMemberPrinted" : [{"_value" : "Sir Vince Cable"} ], "uin" : "125126"} ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 1, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }